The Methotrexate Tablets, cataloged under National Stock Number 6505-01-661-9048, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Gsms Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-661-9048 |
| Primary Part Number | NDC51407-0121-01 |
| Item Name | Methotrexate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Gsms Inc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 100.0 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Protective Storage Feature | ANTINEOPLASTIC DRUG |
| Active Medicament Medicinal Strength | 2.50 MILLIGRAMS METHOTREXATE EQUIVALENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC51407-0121-01 PRIMARY | Gsms Inc (USA) |
| NDC00555-0572-02 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC00054-4550-25 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC00378-0014-01 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| 1455540 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM173479 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-661-9048 is a Methotrexate Tablets, manufactured by Gsms Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-661-9048 has 4 manufacturer part numbers on file: NDC51407-0121-01 (Gsms Inc), NDC00555-0572-02 (Teva Pharmaceuticals Usa, Inc.), NDC00054-4550-25 (Hikma Pharmaceuticals Usa Inc.), NDC00378-0014-01 (Mylan Pharmaceuticals Inc).
Key specifications for NDC51407-0121-01: Administration: ORAL; Primary Container Content Quantity: 100.0 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.